
Markham C. Luke MD PhD
Supervisory Physician, Division Director, U.S. Food and Drug Administration
Join to View Full Profile
10903 New Hampshire AveBuilding 75Silver Spring, MD 20903
Phone+1 301-796-5556
Dr. Luke is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Markham Luke is a dermatologist based in Silver Spring, MD, with an educational background from Johns Hopkins University School of Medicine and residencies completed at the NIH Clinical Center and Washington University. He has been serving as a Division Director at the U.S. Food and Drug Administration since 2016 and as an Associate Professor at the Uniformed Services University of the Health Sciences since 2008. Dr. Luke is also experienced in clinical research, evidence-based medicine, medical education, and consumer product safety. He has authored several publications in scientific journals, including Photoacoustics and Clinical Pharmacology and Therapeutics. Dr. Luke holds the honor of being a Fellow of the American Academy of Dermatology.
Education & Training
- National Institutes of Health Clinical CenterResidency, Dermatology, 1997 - 1999
- Washington University/B-JH/SLCH ConsortiumResidency, Dermatology, 1995 - 1997
- Johns Hopkins UniversityInternship, Internal Medicine, 1994 - 1995
- Johns Hopkins University School of MedicineClass of 1994
Certifications & Licensure
- MD State Medical License 1997 - 2026
Awards, Honors, & Recognition
- Fellow (FAAD) American Academy of Dermatology
Publications & Presentations
PubMed
- 1 citationsNarrow Therapeutic Index Drugs: FDA Experience, Views, and Operations.Mark Donnelly, Lanyan Fang, Rajanikanth Madabushi, Hao Zhu, Markham Luke
Clinical Pharmacology and Therapeutics. 2025-01-01 - 2 citationsQuantitative volumetric photoacoustic assessment of vasoconstriction by topical corticosteroid application in mice skin.Donggyu Kim, Joongho Ahn, Donghyun Kim, Jin Young Kim, Seungah Yoo
Photoacoustics. 2024-12-01 - 1 citationsLocally acting dermatology drug products: Pharmaco-analytic considerations for bioequivalence.Markham C Luke
European Journal of Pharmaceutical Sciences. 2024-08-01
Journal Articles
- Medication Cost‐Savings and Utilization of Generic Inhaled Corticosteroid (ICS) and Long‐Acting Beta‐Agonist (LABA) Drug Products in the USAZhong Wang, Sharon Ahluwalia, Bryan Newman, Sneha Dhapare, Liang Zhao, Markham Luke, Therapeutic Innovation & Regulatory Science, 2/3/2022
- Adverse Effects Lotrisone Cream on InfantLa Grenade L, Vega A, Luke MC, Pediatrics, 12/1/2000
Press Mentions
- Innovation Dispatches from the AADApril 2nd, 2019
- Tattoo Remorse? What You Need to Know About Erasing Your InkJuly 3rd, 2017
Professional Memberships
- Fellow
External Links
- Current Biohttps://www.grxbiosims.org/speakers/markham-luke-m-d-phd/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: